| Tumour heterogeneity in the clinic PL Bedard, AR Hansen, MJ Ratain, LL Siu Nature 501 (7467), 355-364, 2013 | 849 | 2013 |
| The genetic basis for cancer treatment decisions JE Dancey, PL Bedard, N Onetto, TJ Hudson Cell 148 (3), 409-420, 2012 | 303 | 2012 |
| Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012 | 278 | 2012 |
| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium Cancer discovery 7 (8), 818-831, 2017 | 275 | 2017 |
| Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis FE Vera-Badillo, AJ Templeton, P de Gouveia, I Diaz-Padilla, PL Bedard, ... Journal of the National Cancer Institute 106 (1), djt319, 2014 | 264 | 2014 |
| International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy F Cardoso, PL Bedard, EP Winer, O Pagani, E Senkus-Konefka, ... Journal of the National Cancer Institute 101 (17), 1174-1181, 2009 | 251 | 2009 |
| Luminal-B breast cancer and novel therapeutic targets B Tran, PL Bedard Breast Cancer Research 13 (6), 221, 2011 | 203 | 2011 |
| Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance C Kollmannsberger, T Tandstad, PL Bedard, G Cohn-Cedermark, ... J Clin Oncol 33 (1), 51-7, 2015 | 202 | 2015 |
| A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with … PL Bedard, J Tabernero, F Janku, ZA Wainberg, L Paz-Ares, ... Clinical Cancer Research 21 (4), 730-738, 2015 | 182 | 2015 |
| Cancer genomics: technology, discovery, and translation B Tran, JE Dancey, S Kamel-Reid, JD McPherson, PL Bedard, AM Brown, ... J Clin Oncol 30 (6), 647-660, 2012 | 176 | 2012 |
| Sensitive tumour detection and classification using plasma cell-free DNA methylomes SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ... Nature 563 (7732), 579-583, 2018 | 174 | 2018 |
| AKT inhibition in solid tumors with AKT1 mutations DM Hyman, LM Smyth, MTA Donoghue, SN Westin, PL Bedard, EJ Dean, ... Journal of Clinical Oncology 35 (20), 2251, 2017 | 138 | 2017 |
| Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer RK Murthy, S Loi, A Okines, E Paplomata, E Hamilton, SA Hurvitz, NU Lin, ... New England Journal of Medicine 382 (7), 597-609, 2020 | 131 | 2020 |
| A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors TW Chen, AR Razak, PL Bedard, LL Siu, AR Hansen Annals of Oncology 26 (9), 1824-1829, 2015 | 130 | 2015 |
| Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial TL Stockley, AM Oza, HK Berman, NB Leighl, JJ Knox, FA Shepherd, ... Genome medicine 8 (1), 1-12, 2016 | 126 | 2016 |
| Cardiac toxicity with anti-HER-2 therapies-what have we learned so far? E de Azambuja, PL Bedard, T Suter, M Piccart-Gebhart Targeted oncology 4 (2), 77-88, 2009 | 122 | 2009 |
| Abstract S5-07: preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast … HS Rugo, JP Delord, SA Im, PA Ott, SA Piha-Paul, PL Bedard, J Sachdev, ... Cancer research 76 (4 Supplement), S5-07-S5-07, 2016 | 119 | 2016 |
| Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer PL Bedard, A Di Leo, MJ Piccart-Gebhart Nature Reviews Clinical Oncology 7 (1), 22, 2010 | 113 | 2010 |
| Safety and antitumor activity of pembrolizumab in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer HS Rugo, JP Delord, SA Im, PA Ott, SA Piha-Paul, PL Bedard, J Sachdev, ... Clinical Cancer Research 24 (12), 2804-2811, 2018 | 97 | 2018 |
| Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial B Tran, AMK Brown, PL Bedard, E Winquist, GD Goss, SJ Hotte, SA Welch, ... International journal of cancer 132 (7), 1547-1555, 2013 | 89 | 2013 |
Lillian SiuPrincess Margaret Cancer CentreVerified email at uhn.ca
